Björn Nodin

Medicine & Life Sciences

1. Adenocarcinoma 100%
2. Neoplasms 96%
3. Colorectal Neoplasms 77%
4. podocalyxin 64%
5. Survival 61%
6. Biomarkers 57%
7. RNA-Binding Motifs 56%
8. RNA-Binding Proteins 52%
9. Ovarian Epithelial Carcinoma 49%
10. Ovarian Neoplasms 37%
11. Stomach 37%
12. Proteins 36%
13. AT Rich Sequence 31%
14. Cohort Studies 30%
15. Breast Neoplasms 29%
16. Pancreatic Neoplasms 29%
17. Urinary Bladder Neoplasms 27%
18. Recurrence 26%
19. Neoplasm Metastasis 24%
20. Melanoma 19%
21. Polymeric Immunoglobulin Receptors 18%
22. Drug Therapy 17%
23. Thyroid Nuclear Factor 1 16%
24. B-Lymphocytes 16%
25. Plasma Cells 15%
26. Mutation 14%
27. Lung Neoplasms 14%
28. human ERBB2 protein 14%
29. Carrier Proteins 14%
30. Estrogen Receptors 12%
31. beta Catenin 12%
32. Cyclin D1 12%
33. T-Lymphocytes 12%
34. Diet 12%
35. Immunohistochemistry 12%
36. ErbB Receptors 11%
37. Microsatellite Instability 11%
38. Lymph Nodes 11%
39. Non-Small Cell Lung Carcinoma 11%
40. DNA Mismatch Repair 11%
41. Therapeutics 11%
42. Kaplan-Meier Estimate 11%
43. Rectal Neoplasms 11%
44. ezrin 11%
45. Hydroxymethylglutaryl CoA Reductases 10%
46. Population 10%
47. Caveolin 1 10%
48. Antibodies 10%
49. Anthropometry 10%
50. Tumor-Infiltrating Lymphocytes 9%